Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Xolair Prescribers for Allergies (US)(?)

Council Members in this Study Group: 21

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Mitchell Boxer, MD
Assistant Clinical Professor
Albert Einstein College of Medicine

Mitchell Boxer, MD, is Director of the Adult Allergy Section at Long Island Jewish Medical Center and Assistant Clinical Professor at Albert Einstein Medical College. Dr. Boxer completed his fellowship at Northwestern University Medical College and has expertise in a wide range of allergic and immunologic...

Mark Vandewalker, MD
Allergy Specialist and Partner
Allergy & Asthma Consultants Of The Ozarks Ltd

Mark Vandewalker, MD, is an Allergy Specialist at Allergy and Asthma Consultants and he is the Medical Director at Clinical Research of the Ozarks in Missouri. Dr. Vandewalker is board-certified in Pediatric Allergy and has been practicing for almost 25 years. His areas of expertise include allergic...

Michael Kallay, MD
Associate Professor of Medicine
University Of Rochester Medical Center

Michael Kallay, MD, is Associate Professor of Medicine at the University of Rochester. His expertise is in asthma, exercise physiology and COPD, and interstitial lung diseases and his research interest in the management of interstitial lung diseases. Dr. Kallay has been a principal investigator in over...

David Engler, MD, Physician, The Allergy ClinicDavid Engler, MD
Physician
The Allergy Clinic

David Engler, MD, a graduate of Baylor College of Medicine, has worked at The Allergy Clinic since 1991. He has served two terms on the Board of Regents of the American College of Allergy, Asthma & Immunology, and has represented that organization at the A.M.A. Dr. Engler has a busy sub-specialty...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
They'll fix this before the end of the month | 07-02-2008
Analysis of: Medicare fees to doctors fall Tuesday | news.yahoo.com
Author: David Engler, MD, Physician, The Allergy Clinic

If this isn't fixed, it won't be long before cognitive specialties, like internal medicine and neurology, start capping their practices and not allowing new Medicare patients.    

This may have a market after all | 07-02-2008
Author: David Engler, MD, Physician, The Allergy Clinic

Here comes a prescription version of generic Zyrtec syrup.  At first glance, we wonder how it will compete with over the counter Zyrtec.  But wait...there may be a market for this drug    

Next-Generation Xolair (omalizumab) sounds pretty good | 06-18-2008
Author: David Engler, MD, Physician, The Allergy Clinic

This drug seems much more effective at reducing free-IgE levels than is Xolair.  Overall, Xolair has given many patients a tremendous improvement in their quality of life, but it hasn't fulfilled many of its promises. Frankly, some of Xolair's benefits are disappointing, particularly in the 40...

Will Xolair Become Obsolete in the Treatment of Allergies? | 06-10-2008
Author: Mark Vandewalker, MD, Allergy Specialist and Partner, Allergy & Asthma Consultants Of The Ozarks Ltd

This recent report characterizes a newly discovered anti-IgE monoclonal antibody (mAb12) which appears dramatically more potent than omalizumab (Xolair) in its ability to reduce systemic IgE levels. If further studies confirm this enhanced reduction of IgE and IgE-bearing cells, mAb12 has significant...

Xyzal--Just overpriced Zyrtec | 04-04-2008
Author: David Engler, MD, Physician, The Allergy Clinic

 A bottle of 30 Generic Zyrtec can be purchased for $15.  No one is going to get Xyzal that inexpensively. There are no head to head studies showing Xyzal to be better than Zyrtec.  Even though Xyzal claims a 6% sedation rate compared to Zyrtec's 14% rate, it's not apples to apples. ...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic
  • Laboratory, Independent

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Director
  • Partner
  • Physician - Director
  • Physician - Division Head
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T01:45:24.617